Back
About the Global Fund
People & Structures
Back
Funding Model
Investments & Results
-
Explore contributions, investments and results in our fight against AIDS, tuberculosis and malaria around the world.
- Data Explorer
- Funding Decisions
- Data Service
HIV & AIDS
Tuberculosis
Malaria
Back
News
-
14 September 2020
Global Fund Partnership Has Saved 38 Million Lives – but COVID-19 Could Wipe Out Progress -
03 September 2020
Qatar Increases its Contribution to the Global Fund Fivefold -
10 August 2020
Global Fund Launches Search for Inspector General -
26 June 2020
Global Fund Appoints New Chief Financial Officer
Updates
-
24 September 2020
COVID-19 Situation Report -
18 September 2020
COVID-19 Response: Procurement of Automated Polymerase Chain Reaction Diagnostic Tests -
15 September 2020
COVID-19 Response: Antigen-Detection Diagnostic Test Procurement -
14 September 2020
Global Fund Partnership Has Saved 38 Million Lives – but COVID-19 Could Wipe Out Progress
Stories
-
21 September 2020
COVID-19 is a Turning Point for Infectious Diseases -
14 September 2020
Myanmar Makes Major Progress Fighting Malaria -
14 September 2020
Eswatini Meets Global 95-95-95 HIV Target -
14 September 2020
The Stakes Could Not Be Higher: Peter Sands on the Global Fund’s 2020 Results -
14 September 2020
Nombasa’s Fight Against HIV, TB and COVID-19 -
27 August 2020
COVID-19 Response: Preventing Fraud and Abuse
Back
Featured Publication
Documents by type
GF/B25/EDP14
Approved by the Board on: 11 March 2012
Discontinuation of Funding for the Guyana HSS grant (GYA-809-G05-S)
The Board declines approval of additional funding for the next implementation period for them Round 8 Guyana HSS (GYA-809-G05-S) grant.
See attached table.
-
Related Resources
-
bm25_edp14_annex_en.pdf
download in English
-
bm25_edp14_annex_en.pdf
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website. To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.